DraftKings (DKNG) Stock Falls 10% on Senate Betting Bill and NCAA Lawsuit

TLDR

• DKNG fell ~10% on Wednesday, trading around $22.52, on very low volume — down 82% from its average session
• A Senate betting bill was read as negative for DraftKings, triggering a sharp sell-off
• The NCAA sued DraftKings to block use of “March Madness” trademarks during peak tournament betting season
• DraftKings previously cut its 2026 revenue guidance to $6.5–6.9B, missing Wall Street estimates by over $600M
• Analysts still hold a “Moderate Buy” consensus with an average price target of $37.09, well above current levels

---

DraftKings (DKNG) stock is trading at around $22.52 on Wednesday, down roughly 10% on the day.

DraftKings Inc., DKNG

Wednesday’s drop comes as two separate headwinds hit at once. A Senate betting bill development was interpreted by the market as unfavorable to DraftKings, while the NCAA filed a lawsuit seeking to block the company from using tournament-related trademarks like “March Madness.”

The timing of the NCAA lawsuit is particularly awkward. It landed right in the middle of the tournament season — one of the busiest and most lucrative periods of the year for sports betting operators. Any marketing limits or injunctions could dent promotional activity and short-term revenue.

Volume on Wednesday was just over 2.8 million, roughly 82% below the average session volume of 15.6 million. That kind of thin trading can amplify price moves in either direction.

This is not the first rough stretch for DKNG in 2026. Earlier this year, management guided full-year revenue to $6.5–6.9 billion, a number that fell more than $600 million short of Wall Street expectations. The stock took a mid-teens hit after that announcement and has been under pressure since.

Guidance Cut Stings After Strong 2025

The guidance miss was especially frustrating given how strong the Q4 2025 numbers were. Revenue came in at roughly $1.99 billion, up 43% year-on-year. Adjusted EBITDA more than tripled to around $620 million for the full year, and the company posted positive net income for the first time.

DraftKings delivered what investors had been waiting for — and then softened the outlook. That whiplash reset the growth narrative heading into 2026.

The stock is now well below both its 50-day moving average of $26.39 and its 200-day moving average of $32.01, reflecting the sustained pressure since the guidance update.

On the competitive front, DraftKings has been pricing aggressively. Research during March Madness found DKNG offering the most competitive average vig among major operators on money-line and total bets. That keeps customers engaged but puts pressure on margins.

Analysts Still Bullish, But Targets Have Come Down

Wall Street hasn’t given up on the stock. Twenty-five analysts rate it a Buy, five a Hold, and two a Sell. The average 12-month price target sits at $37.09 — more than 60% above Wednesday’s trading price.

Mizuho trimmed its target from $46 to $44 but kept an “outperform” rating. Stifel cut from $44 to $40, maintaining a “buy.” Jefferies holds a $46 target. Wells Fargo reaffirmed an “overweight.”

On the insider front, Director Harry Sloan purchased 100,000 shares at $21.85 in February — a $2.185 million bet that the stock was cheap at those levels. That purchase now sits roughly in line with current prices.

Insiders overall have sold around 549,495 shares in the past 90 days, though they still own 47.08% of the company. Institutional ownership stands at 37.7%.

The stock is sitting near its 52-week lows, with the market cap around $10.63 billion and a beta of 1.67.

The post DraftKings (DKNG) Stock Falls 10% on Senate Betting Bill and NCAA Lawsuit appeared first on CoinCentral.